TAHER, A. T. Et Al. 2012. Deferasirox reduces iron overload significantly in nontransfusion-dependent thalassemia: 1-year results from a prospective, randomized, double-blind, placebo-controlled study. BLOOD , vol.120, no.5 , 970-977.

TAHER, A. T., Porter, J., VIPRAKASIT, V., KATTAMIS, A., CHUNCHARUNEE, S., SUTCHARITCHAN, P., ... SIRITANARATKUL, N.(2012). Deferasirox reduces iron overload significantly in nontransfusion-dependent thalassemia: 1-year results from a prospective, randomized, double-blind, placebo-controlled study. BLOOD , vol.120, no.5, 970-977.

TAHER, Ali Et Al. "Deferasirox reduces iron overload significantly in nontransfusion-dependent thalassemia: 1-year results from a prospective, randomized, double-blind, placebo-controlled study," BLOOD , vol.120, no.5, 970-977, 2012

TAHER, Ali T. Et Al. "Deferasirox reduces iron overload significantly in nontransfusion-dependent thalassemia: 1-year results from a prospective, randomized, double-blind, placebo-controlled study." BLOOD , vol.120, no.5, pp.970-977, 2012

TAHER, A. T. Et Al. (2012) . "Deferasirox reduces iron overload significantly in nontransfusion-dependent thalassemia: 1-year results from a prospective, randomized, double-blind, placebo-controlled study." BLOOD , vol.120, no.5, pp.970-977.

@article{article, author={Ali T. TAHER Et Al. }, title={Deferasirox reduces iron overload significantly in nontransfusion-dependent thalassemia: 1-year results from a prospective, randomized, double-blind, placebo-controlled study}, journal={BLOOD}, year=2012, pages={970-977} }